|
1
|
Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status.
|
J Clin Oncol
|
2011
|
3.59
|
|
2
|
Benign retroperitoneal schwannoma: a case series and review of the literature.
|
Urology
|
2003
|
2.62
|
|
3
|
Detection of occult lymph node metastases in locally advanced node-negative prostate cancer.
|
J Clin Oncol
|
2006
|
2.55
|
|
4
|
International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy.
|
J Clin Oncol
|
2002
|
2.51
|
|
5
|
Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results.
|
J Urol
|
2004
|
2.50
|
|
6
|
Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study.
|
J Urol
|
2011
|
2.14
|
|
7
|
Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
|
J Urol
|
2006
|
2.01
|
|
8
|
Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma.
|
J Clin Oncol
|
2004
|
2.00
|
|
9
|
Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival.
|
Hum Pathol
|
2007
|
1.74
|
|
10
|
Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer.
|
J Urol
|
2007
|
1.74
|
|
11
|
Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study.
|
Eur Urol
|
2011
|
1.65
|
|
12
|
Long-term outcomes of open radical retropubic prostatectomy for clinically localized prostate cancer in the prostate-specific antigen era.
|
Urology
|
2012
|
1.58
|
|
13
|
Radical cystectomy in the elderly: Comparison of survival between younger and older patients.
|
Cancer
|
2005
|
1.55
|
|
14
|
Combination of molecular alterations and smoking intensity predicts bladder cancer outcome: a report from the Los Angeles Cancer Surveillance Program.
|
Cancer
|
2013
|
1.51
|
|
15
|
Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure.
|
World J Urol
|
2006
|
1.48
|
|
16
|
A novel precision-engineered microfiltration device for capture and characterisation of bladder cancer cells in urine.
|
Eur J Cancer
|
2013
|
1.45
|
|
17
|
Radical cystectomy for primary neuroendocrine tumors of the bladder: the university of southern california experience.
|
J Urol
|
2005
|
1.45
|
|
18
|
Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node-positive bladder cancer who are unfit for or who decline adjuvant chemotherapy.
|
BJU Int
|
2014
|
1.44
|
|
19
|
Does reflux in orthotopic diversion matter? A randomized prospective comparison of the Studer and T-pouch ileal neobladders.
|
World J Urol
|
2008
|
1.44
|
|
20
|
Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
|
J Urol
|
2007
|
1.41
|
|
21
|
Postoperative radiotherapy in 423 patients with pT3N0 prostate cancer.
|
Int J Radiat Oncol Biol Phys
|
2002
|
1.40
|
|
22
|
Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.
|
J Urol
|
2003
|
1.39
|
|
23
|
Generation of a concise gene panel for outcome prediction in urinary bladder cancer.
|
J Clin Oncol
|
2009
|
1.32
|
|
24
|
Radical cystectomy in the elderly: comparison of clincal outcomes between younger and older patients.
|
Cancer
|
2005
|
1.28
|
|
25
|
Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer.
|
J Urol
|
2006
|
1.16
|
|
26
|
Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients.
|
J Urol
|
2005
|
1.13
|
|
27
|
Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy.
|
J Urol
|
2005
|
1.13
|
|
28
|
Long-term outcome in patients with a Gleason score ≤ 6 prostate cancer treated by radical prostatectomy.
|
BJU Int
|
2011
|
1.10
|
|
29
|
A critical analysis of perioperative mortality from radical cystectomy.
|
J Urol
|
2006
|
1.10
|
|
30
|
The management of urethral transitional cell carcinoma after radical cystectomy for invasive bladder cancer.
|
J Urol
|
2004
|
1.10
|
|
31
|
Cystoprostatectomy and orthotopic ileal neobladder reconstruction for management of bacille Calmette Guérin-induced bladder contractures.
|
Urology
|
2005
|
1.06
|
|
32
|
Re: Ureteroenteric anastomotic strictures after radical cystectomy--does operative approach matter?: C. B. Anderson, T. M. Morgan, S. Kappa, D. Moore, P. E. Clark, R. Davis, D. F. Penson, D. A. Barocas, J. A. Smith, Jr., M. S. Cookson and S. S. Chang. J Urol 2013; 189: 541-547.
|
J Urol
|
2013
|
1.06
|
|
33
|
Microscopic and gross extravesical extension in pathological staging of bladder cancer.
|
J Urol
|
2004
|
1.03
|
|
34
|
Pubovaginal slings for stress urinary incontinence following radical cystectomy and orthotopic neobladder reconstruction in women.
|
J Urol
|
2004
|
1.03
|
|
35
|
The role of lymphadenectomy in high-grade invasive bladder cancer.
|
Urol Clin North Am
|
2005
|
1.03
|
|
36
|
Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades.
|
BJU Int
|
2013
|
1.03
|
|
37
|
Surgical atlas. Radical cystectomy.
|
BJU Int
|
2004
|
1.01
|
|
38
|
Surgery and adjunctive chemotherapy for invasive bladder cancer.
|
Surg Oncol
|
2002
|
1.00
|
|
39
|
Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy.
|
J Urol
|
2009
|
0.96
|
|
40
|
Indications and technique of the orthotopic neobladder in women.
|
Urol Clin North Am
|
2002
|
0.92
|
|
41
|
Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer.
|
J Urol
|
2009
|
0.92
|
|
42
|
Surgical benchmarks for the treatment of invasive bladder cancer.
|
Urol Oncol
|
2007
|
0.91
|
|
43
|
Variability in surgical quality in a phase III clinical trial of radical cystectomy in patients with organ-confined, node-negative urothelial carcinoma of the bladder.
|
J Surg Oncol
|
2015
|
0.91
|
|
44
|
Natural history of surgically treated bladder carcinoma with extravesical tumor extension.
|
Cancer
|
2003
|
0.91
|
|
45
|
Continent lower urinary tract reconstruction in the cervical spinal cord injured population.
|
J Urol
|
2003
|
0.89
|
|
46
|
Lymphadenectomy for invasive bladder cancer. II. technical aspects and prognostic factors.
|
BJU Int
|
2006
|
0.88
|
|
47
|
The orthotopic T pouch ileal neobladder: experience with 209 patients.
|
J Urol
|
2004
|
0.88
|
|
48
|
Postchemotherapy residual masses in advanced seminoma: current management and outcomes.
|
Expert Rev Anticancer Ther
|
2005
|
0.88
|
|
49
|
Prognostic significance of neuroendocrine expression in lymph node-positive prostate cancer.
|
Urology
|
2006
|
0.86
|
|
50
|
Prognosis of seminal vesicle involvement by transitional cell carcinoma of the bladder.
|
J Urol
|
2004
|
0.85
|
|
51
|
Pathological guidelines for orthotopic urinary diversion in women with bladder cancer: a review of the literature.
|
J Urol
|
2007
|
0.85
|
|
52
|
Lymphadenectomy for invasive bladder cancer: I. historical perspective and contemporary rationale.
|
BJU Int
|
2006
|
0.81
|
|
53
|
Prostate-sparing cystectomy: a review of the oncologic and functional outcomes. Contraindicated in patients with bladder cancer.
|
Urol Oncol
|
2008
|
0.81
|
|
54
|
The evolving role of pelvic lymphadenectomy in the treatment of bladder cancer.
|
Urol Oncol
|
2004
|
0.80
|
|
55
|
Molecular targets and targeted therapies in bladder cancer management.
|
World J Urol
|
2008
|
0.78
|
|
56
|
Adjuvant chemotherapy for locally advanced urothelial carcinoma: an overview of the USC experience.
|
World J Urol
|
2008
|
0.78
|
|
57
|
The craft of urologic surgery: the T pouch.
|
Urol Clin North Am
|
2003
|
0.77
|
|
58
|
Renal epithelioid angiomyolipoma associated with hyperprolactinemia.
|
Urology
|
2005
|
0.77
|
|
59
|
Outcomes of patients with clinical CIS-only disease treated with radical cystectomy.
|
World J Urol
|
2008
|
0.77
|
|
60
|
Outcome in patients with exclusive carcinoma in situ (CIS) after radical cystectomy.
|
BJU Int
|
2013
|
0.76
|
|
61
|
Continent right colon reservoir using a cutaneous appendicostomy.
|
Urology
|
2004
|
0.76
|
|
62
|
Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle: an update.
|
Urol Oncol
|
2005
|
0.76
|
|
63
|
Surgical Atlas: The orthotopic T-pouch ileal neobladder.
|
BJU Int
|
2006
|
0.76
|
|
64
|
Urinary functional outcomes in female neobladder patients.
|
World J Urol
|
2013
|
0.75
|
|
65
|
Management of bladder cancer and urinary tract reconstruction : dedicated to the memory of John P. Stein, 14 June 1962-11 April 2008.
|
World J Urol
|
2009
|
0.75
|
|
66
|
Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle.
|
Expert Rev Anticancer Ther
|
2005
|
0.75
|
|
67
|
Simple technique to stabilize the costochondral junction using synthetic mesh after a thoracoabdominal incision.
|
Urology
|
2002
|
0.75
|
|
68
|
Subclinical haemostatic activation and current surgeon volume predict bleeding with open radical retropubic prostatectomy.
|
BJU Int
|
2008
|
0.75
|
|
69
|
Legends in urology.
|
Can J Urol
|
2011
|
0.75
|
|
70
|
Hemi-T pouch modification for pediatric urinary diversion.
|
J Urol
|
2003
|
0.75
|